BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu K, Lin K, Li X, Yuan X, Xu P, Ni P, Xu D. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment. Front Immunol 2020;11:1731. [PMID: 32849616 DOI: 10.3389/fimmu.2020.01731] [Cited by in Crossref: 24] [Cited by in F6Publishing: 104] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu C, Yu Q, Shou W, Zhang K, Li Y, Guo W, Bao Q. Co-stimulatory molecule clusters correlate with survival, immune infiltration, and tumor mutation burden in non-small cell lung cancer. All Life 2022;15:760-70. [DOI: 10.1080/26895293.2022.2085814] [Reference Citation Analysis]
2 Li Z, Yu Q, Zhu Q, Yang X, Li Z, Fu J. Applications of machine learning in tumor-associated macrophages. Front Immunol 2022;13:985863. [DOI: 10.3389/fimmu.2022.985863] [Reference Citation Analysis]
3 Gu Y, Zheng Q, Fan G, Liu R. Advances in Anti-Cancer Activities of Flavonoids in Scutellariae radix: Perspectives on Mechanism. IJMS 2022;23:11042. [DOI: 10.3390/ijms231911042] [Reference Citation Analysis]
4 Qin S, Wang Z, Huang C, Huang P, Li D. Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2. Front Immunol 2022;13:955841. [DOI: 10.3389/fimmu.2022.955841] [Reference Citation Analysis]
5 Liang L, He H, Jiang S, Liu Y, Huang J, Sun X, Li Y, Jiang Y, Cong L. TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma. IJMS 2022;23:10415. [DOI: 10.3390/ijms231810415] [Reference Citation Analysis]
6 Zhang X, Bai W, Hu L, Ha H, Du Y, Xiong W, Wang H, Shang P. The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis. Clin Transl Oncol 2022. [PMID: 36071369 DOI: 10.1007/s12094-022-02932-6] [Reference Citation Analysis]
7 Najafi A, Keykhaee M, Khorramdelazad H, Karimi MY, Nejatbakhsh Samimi L, Aghamohamadi N, Karimi M, Falak R, Khoobi M. Catalase application in cancer therapy: Simultaneous focusing on hypoxia attenuation and macrophage reprogramming. Biomedicine & Pharmacotherapy 2022;153:113483. [DOI: 10.1016/j.biopha.2022.113483] [Reference Citation Analysis]
8 Peng C, Li L, Luo G, Tan S, Xia R, Zeng L. Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer. Front Oncol 2022;12:986885. [DOI: 10.3389/fonc.2022.986885] [Reference Citation Analysis]
9 Huang X, Wang Y, Yang W, Dong J, Li L. Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment. Front Nutr 2022;9:974896. [DOI: 10.3389/fnut.2022.974896] [Reference Citation Analysis]
10 Liu J, Ma J, Zhang Q. Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer. Front Genet 2022;13:929870. [DOI: 10.3389/fgene.2022.929870] [Reference Citation Analysis]
11 Yi S, Tao X, Wang Y, Cao Q, Zhou Z, Wang S. Effects of propofol on macrophage activation and function in diseases. Front Pharmacol 2022;13:964771. [DOI: 10.3389/fphar.2022.964771] [Reference Citation Analysis]
12 Struckmeier AK, Radermacher A, Fehrenz M, Bellin T, Alansary D, Wartenberg P, Boehm U, Wagner M, Scheller A, Hess J, Moratin J, Freudlsperger C, Hoffmann J, Thurner L, Roemer K, Freier K, Horn D. IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma. J Cancer Res Clin Oncol 2022. [PMID: 35963900 DOI: 10.1007/s00432-022-04277-7] [Reference Citation Analysis]
13 Rager T, Eckburg A, Patel M, Qiu R, Gantiwala S, Dovalovsky K, Fan K, Lam K, Roesler C, Rastogi A, Gautam S, Dube N, Morgan B, Nasifuzzaman SM, Ramaswami D, Gnanasekar V, Smith J, Merchant A, Puri N. Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies. Cancers 2022;14:3779. [DOI: 10.3390/cancers14153779] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lv B, Wang Y, Ma D, Cheng W, Liu J, Yong T, Chen H, Wang C. Immunotherapy: Reshape the Tumor Immune Microenvironment. Front Immunol 2022;13:844142. [PMID: 35874717 DOI: 10.3389/fimmu.2022.844142] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Guo Y, Mao W, Jin L, Xia L, Huang J, Liu X, Ni P, Shou Q, Fu H. Flavonoid Group of Smilax glabra Roxb. Regulates the Anti-Tumor Immune Response Through the STAT3/HIF-1 Signaling Pathway. Front Pharmacol 2022;13:918975. [DOI: 10.3389/fphar.2022.918975] [Reference Citation Analysis]
16 Kim D, Kim JS, Cheon I, Kim SR, Chun SH, Kim JJ, Lee S, Yoon JS, Hong SA, Won HS, Kang K, Ahn Y, Ko YH. Identification and Characterization of Cancer-Associated Fibroblast Subpopulations in Lung Adenocarcinoma. Cancers 2022;14:3486. [DOI: 10.3390/cancers14143486] [Reference Citation Analysis]
17 Li W, Wu F, Zhao S, Shi P, Wang S, Cui D. Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy. Cytokine Growth Factor Rev 2022:S1359-6101(22)00054-5. [PMID: 35871139 DOI: 10.1016/j.cytogfr.2022.07.004] [Reference Citation Analysis]
18 Sun J, Xu X, Jin L. Effects of Metabolism on Macrophage Polarization Under Different Disease Backgrounds. Front Immunol 2022;13:880286. [DOI: 10.3389/fimmu.2022.880286] [Reference Citation Analysis]
19 Tan Y, Zhao L, Yang Y, Liu W. The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages. Front Oncol 2022;12:953283. [DOI: 10.3389/fonc.2022.953283] [Reference Citation Analysis]
20 Wei Y, Zhang J, Fan X, Zheng Z, Jiang X, Chen D, Lu Y, Li Y, Wang M, Hu M, Du Q, Yang L, Li H, Xiao Y, Li Y, Jin J, Wang D, Yuan X, Li Q. Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor Progression. Front Immunol 2022;13:935552. [DOI: 10.3389/fimmu.2022.935552] [Reference Citation Analysis]
21 Jing W, Peng R, Li X, Lv S, Duan Y, Jiang S, Wang F. Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-15. [DOI: 10.1155/2022/7267131] [Reference Citation Analysis]
22 Wei W, Zhang Y, Song Q, Zhang Q, Zhang X, Liu X, Wu Z, Xu X, Xu Y, Yan Y, Zhao C, Yang J. Transmissible ER stress between macrophages and tumor cells configures tumor microenvironment. Cell Mol Life Sci 2022;79:403. [PMID: 35799071 DOI: 10.1007/s00018-022-04413-z] [Reference Citation Analysis]
23 Zhang J, Yuan X, Wang Y, Liu J, Li Z, Li S, Liu Y, Gong X, Sun Y, Wu W, Sun L, Du S, Wang T. Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma. Front Oncol 2022;12:893132. [DOI: 10.3389/fonc.2022.893132] [Reference Citation Analysis]
24 Zheng Y, Yang X. Application and prospect of single-cell sequencing in cancer metastasis. Future Oncol 2022;18:2723-36. [PMID: 35686493 DOI: 10.2217/fon-2022-0156] [Reference Citation Analysis]
25 Li W, Liu J. The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma. Front Immunol 2022;13:845585. [PMID: 35757728 DOI: 10.3389/fimmu.2022.845585] [Reference Citation Analysis]
26 Li D, Ma H, Shu Q, Wang T, Li L, Huang P, Lou K, Xu H. Arsenite inhibits M2a polarization of macrophages through downregulation of peroxisome proliferator-activated receptor gamma. Toxicol Appl Pharmacol 2022;450:116142. [PMID: 35777529 DOI: 10.1016/j.taap.2022.116142] [Reference Citation Analysis]
27 Yu W, Tu Y, Long Z, Liu J, Kong D, Peng J, Wu H, Zheng G, Zhao J, Chen Y, Liu R, Li W, Hai C, Zhou J. Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/2606928] [Reference Citation Analysis]
28 Zhang Y, Zhang X, Meng Y, Xu X, Zuo D. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype. Int Immunopharmacol 2022;110:108994. [PMID: 35777265 DOI: 10.1016/j.intimp.2022.108994] [Reference Citation Analysis]
29 Liu YQ, Luo M, Shi Y, Guo Y, Zhang H, Yang KD, Li TR, Yang LQ, Liu TT, Huang B, Liu Q, He ZC, Zhang XN, Wang WY, Wang S, Zeng H, Niu Q, Zhang X, Cui YH, Zhang ZR, Bian XW, Ping YF. Dicer deficiency impairs proliferation but potentiates anti-tumoral effect of macrophages in glioblastoma. Oncogene 2022. [PMID: 35764885 DOI: 10.1038/s41388-022-02393-9] [Reference Citation Analysis]
30 Cereceda K, Bravo N, Jorquera R, González-Stegmaier R, Villarroel-Espíndola F. Simultaneous and Spatially-Resolved Analysis of T-Lymphocytes, Macrophages and PD-L1 Immune Checkpoint in Rare Cancers. Cancers (Basel) 2022;14:2815. [PMID: 35681797 DOI: 10.3390/cancers14112815] [Reference Citation Analysis]
31 Liu C, He D, Zhang S, Chen H, Zhao J, Li X, Zeng X. Homogeneous Polyporus Polysaccharide Inhibit Bladder Cancer by Resetting Tumor-Associated Macrophages Toward M1 Through NF-κB/NLRP3 Signaling. Front Immunol 2022;13:839460. [PMID: 35603205 DOI: 10.3389/fimmu.2022.839460] [Reference Citation Analysis]
32 Chen Y, Pal S, Hu Q. Recent advances in biomaterial-assisted cell therapy. J Mater Chem B 2022. [PMID: 35612089 DOI: 10.1039/d2tb00583b] [Reference Citation Analysis]
33 Tao R, Liu Q, Huang R, Wang K, Sun Z, Yang P, Wang J. A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma. Biomed Res Int 2022;2022:3194996. [PMID: 35592520 DOI: 10.1155/2022/3194996] [Reference Citation Analysis]
34 Yang D, Yang L, Cai J, Li H, Xing Z, Hou Y. Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization. Mol Cell Biochem 2022. [PMID: 35590082 DOI: 10.1007/s11010-022-04461-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Su S, Lei A, Wang X, Lu H, Wang S, Yang Y, Li N, Zhang Y, Zhang J. Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies. Cells 2022;11:1652. [PMID: 35626689 DOI: 10.3390/cells11101652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Chang X, Xing P. Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer. Lipids Health Dis 2022;21:43. [PMID: 35562758 DOI: 10.1186/s12944-022-01651-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Russell RC, Guan KL. The multifaceted role of autophagy in cancer. EMBO J 2022;:e110031. [PMID: 35535466 DOI: 10.15252/embj.2021110031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Li Y, Yu Y, Kramer A, Hon R, Wilson M, Brown J, Yang L. An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy. Cells 2022;11:1583. [DOI: 10.3390/cells11091583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Wu K, Liu Y, Liu L, Peng Y, Pang H, Sun X, Xia D. Emerging Trends and Research Foci in Tumor Microenvironment of Pancreatic Cancer: A Bibliometric and Visualized Study. Front Oncol 2022;12:810774. [PMID: 35515122 DOI: 10.3389/fonc.2022.810774] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Yang K, Yen C, Chang R, Wang J, Chen J. CAST as a Potential Oncogene, Identified by Machine Search, in Gastric Cancer Infiltrated with Macrophages and Associated with Lgr5. Biomolecules 2022;12:670. [DOI: 10.3390/biom12050670] [Reference Citation Analysis]
41 Liu Q, Sun W, Zhang H. Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer. Front Pharmacol 2022;13:875384. [DOI: 10.3389/fphar.2022.875384] [Reference Citation Analysis]
42 Kirschenbaum D, Amit I. Brain metastases: Not all tumors are created equal. Neuron 2022;110:1097-9. [PMID: 35390289 DOI: 10.1016/j.neuron.2022.03.027] [Reference Citation Analysis]
43 Lv C, Li S, Zhao J, Yang P, Yang C. M1 Macrophages Enhance Survival and Invasion of Oral Squamous Cell Carcinoma by Inducing GDF15-Mediated ErbB2 Phosphorylation. ACS Omega 2022;7:11405-14. [PMID: 35415372 DOI: 10.1021/acsomega.2c00571] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Zhang L, Chen D, Song D, Liu X, Zhang Y, Xu X, Wang X. Clinical and translational values of spatial transcriptomics. Signal Transduct Target Ther 2022;7:111. [PMID: 35365599 DOI: 10.1038/s41392-022-00960-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
45 Fereydouni M, Motaghed M, Ahani E, Kafri T, Dellinger K, Metcalfe DD, Kepley CL. Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer. Front Oncol 2022;12:830199. [DOI: 10.3389/fonc.2022.830199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Kuske M, Haist M, Jung T, Grabbe S, Bros M. Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses? Cancers (Basel) 2022;14:1710. [PMID: 35406483 DOI: 10.3390/cancers14071710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kolesnikoff N, Chen CH, Samuel MS. Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression. Clin Sci (Lond) 2022;136:361-77. [PMID: 35260891 DOI: 10.1042/CS20210679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Li XY, Shen Y, Zhang L, Guo X, Wu J. Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing. Biochim Biophys Acta Rev Cancer 2022;:188720. [PMID: 35304295 DOI: 10.1016/j.bbcan.2022.188720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Yang X, Lin J, Wang G, Xu D. Targeting Proliferating Tumor-Infiltrating Macrophages Facilitates Spatial Redistribution of CD8+ T Cells in Pancreatic Cancer. Cancers (Basel) 2022;14:1474. [PMID: 35326625 DOI: 10.3390/cancers14061474] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Rentschler M, Braumüller H, Briquez PS, Wieder T. Cytokine-Induced Senescence in the Tumor Microenvironment and Its Effects on Anti-Tumor Immune Responses. Cancers (Basel) 2022;14:1364. [PMID: 35326515 DOI: 10.3390/cancers14061364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
51 Yin Y, Liu B, Cao Y, Yao S, Liu Y, Jin G, Qin Y, Chen Y, Cui K, Zhou L, Bian Z, Fei B, Huang S, Huang Z. Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages. Adv Sci (Weinh) 2022;9:2102620. [PMID: 35356153 DOI: 10.1002/advs.202102620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
52 Zhao J, Huang S, Tan D, Yang K, Chen M, Jia X, Mao X, Xu Y. PGM1 and ENO1 Promote the Malignant Progression of Bladder Cancer via Comprehensive Analysis of the m6A Signature and Tumor Immune Infiltration. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/8581805] [Reference Citation Analysis]
53 Guan Y, Xu B, Sui Y, Chen Z, Luan Y, Jiang Y, Wei L, Long W, Zhao S, Han L, Xu D, Lin L, Guan Q. Pan-Cancer Analysis and Validation Reveals that D-Dimer-Related Genes are Prognostic and Downregulate CD8+ T Cells via TGF-Beta Signaling in Gastric Cancer. Front Mol Biosci 2022;9:790706. [DOI: 10.3389/fmolb.2022.790706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lee-rueckert M, Lappalainen J, Kovanen PT, Escola-gil JC. Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View. Front Cardiovasc Med 2022;9:777822. [DOI: 10.3389/fcvm.2022.777822] [Reference Citation Analysis]
55 Ma J, Chen S, Liu Y, Han H, Gong M, Song Y. The role of exosomal miR-181b in the crosstalk between NSCLC cells and tumor-associated macrophages. Genes Genomics 2022. [PMID: 35150402 DOI: 10.1007/s13258-022-01227-y] [Reference Citation Analysis]
56 Zeng Y, Lin D, Gao M, Du G, Cai Y. Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types. Sci Rep 2022;12:1933. [PMID: 35121770 DOI: 10.1038/s41598-022-05987-1] [Reference Citation Analysis]
57 Ma H, Ding Z, Xie Y, Li L, Li D, Lou K, Wang W, Xu H. Methylglyoxal produced by tumor cells through formaldehyde-enhanced Warburg effect potentiated polarization of tumor-associated macrophages. Toxicology and Applied Pharmacology 2022. [DOI: 10.1016/j.taap.2022.115910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Meng X, Wang X, Jiang C, Zhang S, Cheng S. Correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer. Transl Oncol 2022;18:101355. [PMID: 35121221 DOI: 10.1016/j.tranon.2022.101355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Wen S, Jiang Y, Liang S, Cheng Z, Zhu X, Guo Q. Opioids Regulate the Immune System: Focusing on Macrophages and Their Organelles. Front Pharmacol 2021;12:814241. [PMID: 35095529 DOI: 10.3389/fphar.2021.814241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Ding X, Sun X, Cai H, Wu L, Liu Y, Zhao Y, Zhou D, Yu G, Zhou X. Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy. Front Oncol 2021;11:786913. [PMID: 35070992 DOI: 10.3389/fonc.2021.786913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Niu Y, Chen J, Qiao Y. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe. Front Immunol 2022;13:836223. [DOI: 10.3389/fimmu.2022.836223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Maisel BA, Yi M, Peck AR, Sun Y, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Nevalainen MT, Tanaka T, Simone N, Wang LL, Rui H, Chervoneva I. Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer. Cancers (Basel) 2022;14:308. [PMID: 35053472 DOI: 10.3390/cancers14020308] [Reference Citation Analysis]
63 You Y, Tian Z, Du Z, Wu K, Xu G, Dai M, Wang Y, Xiao M. M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop. J Exp Clin Cancer Res 2022;41:10. [PMID: 34991668 DOI: 10.1186/s13046-021-02222-z] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
64 Wang X, Wang J, Zhao J, Wang H, Chen J, Wu J. HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment. Theranostics 2022;12:963-75. [PMID: 34976223 DOI: 10.7150/thno.65411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Li T, Jin K, Li H, Ye L, Li P, Jiang B, Lin X, Liao Z, Zhang H, Shi S, Lin M, Fei Q, Xiao Z, Xu H, Liu L, Yu X, Wu W. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.01.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Wang C, Ma C, Gong L, Guo Y, Fu K, Zhang Y, Zhou H, Li Y. Macrophage Polarization and Its Role in Liver Disease. Front Immunol 2021;12:803037. [PMID: 34970275 DOI: 10.3389/fimmu.2021.803037] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
67 Guo L, Yang H, Zhou C, Shi Y, Huang L, Zhang J. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy. Front Immunol 2021;12:773570. [PMID: 34956201 DOI: 10.3389/fimmu.2021.773570] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
68 Zhang Q, Li S, Bai L, Yu D, Li H, Tong R. Self-Delivery Janus-Prodrug for Precise Immuno-Chemotherapy of Colitis-Associated Colorectal Cancer. ACS Appl Mater Interfaces 2021. [PMID: 34958191 DOI: 10.1021/acsami.1c20031] [Reference Citation Analysis]
69 Liu M, Zhang L, Zhou Q, Wang Y, Sun Q, Ren X. The Distinct Impact of TAM Infiltration on the Prognosis of Patients With Cardia and Non-Cardia Gastric Cancer and Its Association With H. pylori Infection. Front Oncol 2021;11:737061. [PMID: 34926251 DOI: 10.3389/fonc.2021.737061] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Neganova M, Liu J, Aleksandrova Y, Klochkov S, Fan R. Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers (Basel) 2021;13:6062. [PMID: 34885171 DOI: 10.3390/cancers13236062] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
71 Kong X, Zhu M, Wang Z, Xu Z, Shao J. Characteristics and clinical significance of CD163+/CD206+M2 mono-macrophage in the bladder cancer microenvironment. Turk J Biol 2021;45:624-32. [PMID: 34803459 DOI: 10.3906/biy-2104-17] [Reference Citation Analysis]
72 Chen Q, Li Y, Gao W, Chen L, Xu W, Zhu X. Exosome-Mediated Crosstalk Between Tumor and Tumor-Associated Macrophages. Front Mol Biosci 2021;8:764222. [PMID: 34722637 DOI: 10.3389/fmolb.2021.764222] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
73 Xu T, Yu S, Zhang J, Wu S. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers. J Hematol Oncol 2021;14:181. [PMID: 34717710 DOI: 10.1186/s13045-021-01198-9] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
74 Wang G, Yang L, Gao J, Mu H, Song Y, Jiang X, Chen B, Cui R. Identification of Candidate Biomarker ASXL2 and Its Predictive Value in Pancreatic Carcinoma. Front Oncol 2021;11:736694. [PMID: 34692512 DOI: 10.3389/fonc.2021.736694] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
75 Zhou Y, Liu S, Liu C, Yang J, Lin Q, Zheng S, Chen C, Zhou Q, Chen R. Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor. Int J Biol Sci 2021;17:3760-75. [PMID: 34671197 DOI: 10.7150/ijbs.61717] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Dong B, Wu C, Huang L, Qi Y. Macrophage-Related SPP1 as a Potential Biomarker for Early Lymph Node Metastasis in Lung Adenocarcinoma. Front Cell Dev Biol 2021;9:739358. [PMID: 34646827 DOI: 10.3389/fcell.2021.739358] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
77 Nikovics K, Favier AL. Macrophage Identification In Situ. Biomedicines 2021;9:1393. [PMID: 34680510 DOI: 10.3390/biomedicines9101393] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Khalyfa A, Qiao Z, Raju M, Shyu CR, Coghill L, Ericsson A, Gozal D. Monocarboxylate Transporter-2 Expression Restricts Tumor Growth in a Murine Model of Lung Cancer: A Multi-Omic Analysis. Int J Mol Sci 2021;22:10616. [PMID: 34638954 DOI: 10.3390/ijms221910616] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Grosser B, Glückstein MI, Dhillon C, Schiele S, Dintner S, VanSchoiack A, Kroeppler D, Martin B, Probst A, Vlasenko D, Schenkirsch G, Märkl B. Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes. J Pathol 2021. [PMID: 34580877 DOI: 10.1002/path.5810] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
80 Chu PY, Tzeng YT, Chiu YH, Lin HY, Kuo CH, Hou MF, Li CJ. Multi-Omics Reveals the Immunological Role and Prognostic Potential of Mitochondrial Ubiquitin Ligase MARCH5 in Human Breast Cancer. Biomedicines 2021;9:1329. [PMID: 34680446 DOI: 10.3390/biomedicines9101329] [Reference Citation Analysis]
81 Yu TT, Sang XY, Han N, Peng XC, Li QR, Xu X, Xiao RC, Xu HZ, Chen X, Wang MF, Li TF. Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming. Int Immunopharmacol 2021;100:108164. [PMID: 34562845 DOI: 10.1016/j.intimp.2021.108164] [Reference Citation Analysis]
82 Wang M, Li C, Liu Y, Wang Z. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer. Biomed Res Int 2021;2021:6428873. [PMID: 34414238 DOI: 10.1155/2021/6428873] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
83 Liu Y, Zhou X, Wang X. Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. J Hematol Oncol 2021;14:125. [PMID: 34404434 DOI: 10.1186/s13045-021-01134-x] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
84 Liu C, Zhang W, Wang J, Si T, Xing W. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling. Cancer Sci 2021. [PMID: 34375482 DOI: 10.1111/cas.15101] [Reference Citation Analysis]
85 Tang LJW, Zaseela A, Toh CCM, Adine C, Aydar AO, Iyer NG, Fong ELS. Engineering stromal heterogeneity in cancer. Adv Drug Deliv Rev 2021;175:113817. [PMID: 34087326 DOI: 10.1016/j.addr.2021.05.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
86 Cheng G, Dong H, Yang C, Liu Y, Wu Y, Zhu L, Tong X, Wang S. A review on the advances and challenges of immunotherapy for head and neck cancer. Cancer Cell Int 2021;21:406. [PMID: 34332576 DOI: 10.1186/s12935-021-02024-5] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
87 Gunaydin G. CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion. Front Oncol 2021;11:668349. [PMID: 34336660 DOI: 10.3389/fonc.2021.668349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
88 Lavy M, Gauttier V, Poirier N, Barillé-Nion S, Blanquart C. Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities. Front Immunol 2021;12:702785. [PMID: 34276698 DOI: 10.3389/fimmu.2021.702785] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
89 Botta C, Mendicino F, Martino EA, Vigna E, Ronchetti D, Correale P, Morabito F, Neri A, Gentile M. Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities. Cancers (Basel) 2021;13:3213. [PMID: 34203150 DOI: 10.3390/cancers13133213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Cai H, Zhang Y, Wang J, Gu J. Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1. Front Immunol 2021;12:690869. [PMID: 34248982 DOI: 10.3389/fimmu.2021.690869] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
91 Kähkönen TE, Halleen JM, Bernoulli J. Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis. Cells 2021;10:1529. [PMID: 34204474 DOI: 10.3390/cells10061529] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
92 Tan Y, Wang M, Zhang Y, Ge S, Zhong F, Xia G, Sun C. Tumor-Associated Macrophages: A Potential Target for Cancer Therapy. Front Oncol 2021;11:693517. [PMID: 34178692 DOI: 10.3389/fonc.2021.693517] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
93 Poh AR, Ernst M. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges. Cancers (Basel) 2021;13:2860. [PMID: 34201127 DOI: 10.3390/cancers13122860] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
94 Hendricks-Wenger A, Hutchison R, Vlaisavljevich E, Allen IC. Immunological Effects of Histotripsy for Cancer Therapy. Front Oncol 2021;11:681629. [PMID: 34136405 DOI: 10.3389/fonc.2021.681629] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
95 Guan Y, Du Y, Wang G, Gou H, Xue Y, Xu J, Li E, Chan DW, Wu D, Xu P, Ni P, Xu D, Hu Y. Overexpression of PLXDC2 in Stromal Cell-Associated M2 Macrophages Is Related to EMT and the Progression of Gastric Cancer. Front Cell Dev Biol 2021;9:673295. [PMID: 34124056 DOI: 10.3389/fcell.2021.673295] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
96 Balta E, Wabnitz GH, Samstag Y. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors. Int J Mol Sci 2021;22:5736. [PMID: 34072260 DOI: 10.3390/ijms22115736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
97 Lin Y, Chen D, Ding Q, Zhu X, Zhu R, Chen Y. [Progress in Single-cell RNA Sequencing of Lung Adenocarcinoma]. Zhongguo Fei Ai Za Zhi 2021;24:434-40. [PMID: 34024063 DOI: 10.3779/j.issn.1009-3419.2021.102.19] [Reference Citation Analysis]
98 Chakiryan NH, Kimmel GJ, Kim Y, Hajiran A, Aydin AM, Zemp L, Katende E, Nguyen J, Lopez-Blanco N, Chahoud J, Spiess PE, Fournier M, Dhillon J, Wang L, Moran-Segura C, El-Kenawi A, Mulé J, Altrock PM, Manley BJ. Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma. PLoS One 2021;16:e0245415. [PMID: 33882057 DOI: 10.1371/journal.pone.0245415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Carvajal L, Gutiérrez J, Morselli E, Leiva A. Autophagy Process in Trophoblast Cells Invasion and Differentiation: Similitude and Differences With Cancer Cells. Front Oncol 2021;11:637594. [PMID: 33937039 DOI: 10.3389/fonc.2021.637594] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
100 Liang T, Zhang R, Liu X, Ding Q, Wu S, Li C, Lin Y, Ye Y, Zhong Z, Zhou M. Recent Advances in Macrophage-Mediated Drug Delivery Systems. Int J Nanomedicine 2021;16:2703-14. [PMID: 33854316 DOI: 10.2147/IJN.S298159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Sadozai H, Acharjee A, Gruber T, Gloor B, Karamitopoulou E. Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity. Cancers (Basel) 2021;13:1090. [PMID: 33806316 DOI: 10.3390/cancers13051090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
102 Kashima Y, Togashi Y, Fukuoka S, Kamada T, Irie T, Suzuki A, Nakamura Y, Shitara K, Minamide T, Yoshida T, Taoka N, Kawase T, Wada T, Inaki K, Chihara M, Ebisuno Y, Tsukamoto S, Fujii R, Ohashi A, Suzuki Y, Tsuchihara K, Nishikawa H, Doi T. Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimens. Sci Rep 2021;11:341. [PMID: 33431933 DOI: 10.1038/s41598-020-79385-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
103 Zhao Y, Liu X, Huo M, Wang Y, Li Y, Xu N, Zhu H. Cetuximab enhances the anti-tumor function of macrophages in an IL-6 dependent manner. Life Sci 2021;267:118953. [PMID: 33359746 DOI: 10.1016/j.lfs.2020.118953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
104 Liu W, Stachura P, Xu HC, Bhatia S, Borkhardt A, Lang PA, Pandyra AA. Senescent Tumor CD8+ T Cells: Mechanisms of Induction and Challenges to Immunotherapy. Cancers (Basel) 2020;12:E2828. [PMID: 33008037 DOI: 10.3390/cancers12102828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]